The human tri-peptide GHK and tissue remodeling
Widemann BC, Schwartz S, Jayaprakash N, Christensen R, Pui CH, Chauhan N, Daugherty C, King TR, Rush JE, Howard SC
Patients develop early-onset neurological manifestations and neurodevelopmental disorders that are currently incurable ( The pathophysiological mechanisms underlying most mitochondrial diseases causing neurodevelopmental disorders are poorly understood
Between these, Novo Nordisk may have the more recognizable brands in the GLP-1 space, as it is the maker of both Ozempic and Wegovy
Hepatoprotective effect of BPC 157, a 15-amino acid peptide, on liver lesions induced by either restraint stress or bile duct and hepatic artery ligation or CCl4 administration